{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:59:15Z","timestamp":1786996755487,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.seizure.2020.01.002","type":"journal-article","created":{"date-parts":[[2020,1,5]],"date-time":"2020-01-05T21:42:36Z","timestamp":1578260556000},"page":"101-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Levetiracetam and cutaneous adverse reactions: A systematic review of descriptive studies"],"prefix":"10.1016","volume":"75","author":[{"given":"Muhammed","family":"Rashid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha K","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manik","family":"Chhabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananth","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.seizure.2020.01.002_bib0005","doi-asserted-by":"crossref","first-page":"106","DOI":"10.14581\/jer.17016","article-title":"Levetiracetam-induced skin hyperpigmentation: an extremely rare undesirable side effect","volume":"7","author":"Algahtani","year":"2017","journal-title":"J Epilepsy Res"},{"key":"10.1016\/j.seizure.2020.01.002_bib0010","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2147\/NDT.S2937","article-title":"Levetiracetam in the treatment of epilepsy","volume":"3","author":"Abou-Khalil","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"2","key":"10.1016\/j.seizure.2020.01.002_bib0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0163-7258(99)00052-2","article-title":"Pharmacokinetic profile of Levetiracetam: toward ideal characteristics","volume":"85","author":"Patsalos","year":"2000","journal-title":"Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.seizure.2020.01.002_bib0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1528-1167.2001.00005.x","article-title":"Pharmacokinetics of levetiracetam","volume":"42","author":"Radtke","year":"2001","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.seizure.2020.01.002_bib0025","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3109\/00207454.2013.866951","article-title":"The adverse effects profile of levetiracetam in epilepsy: a more detailed look","volume":"124","author":"Mbizvo","year":"2014","journal-title":"Int J Neurosci"},{"issue":"9","key":"10.1016\/j.seizure.2020.01.002_bib0030","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/ijd.14411","article-title":"Valproic acid and Stevens\u2010Johnson syndrome: a systematic review of descriptive studies","volume":"58","author":"Rashid","year":"2019","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.seizure.2020.01.002_bib0035","doi-asserted-by":"crossref","first-page":"112","DOI":"10.5530\/jyp.2019.11.24","article-title":"Ataxia, manifestation of phenytoin toxicity: a case report","volume":"11","author":"Juhi","year":"2019","journal-title":"J Young Pharm"},{"issue":"3","key":"10.1016\/j.seizure.2020.01.002_bib0040","article-title":"A Rare case of DRESS (Drug reaction with eosinophilia and systemic symptoms) syndrome with cholecystitis in a patient on levetiracetam","volume":"11","author":"Singh","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.seizure.2020.01.002_bib0045","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.seizure.2012.09.005","article-title":"Steven-Johnson syndrome induced by Levetiracetam","volume":"21","author":"Zou","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2020.01.002_bib0050","doi-asserted-by":"crossref","first-page":"e944","DOI":"10.1097\/MJT.0000000000000105","article-title":"Rare Red Rashes: a case report of Levetiracetam-induced cutaneous reaction and review of literature","volume":"23","author":"Jones","year":"2016","journal-title":"Am J Ther"},{"key":"10.1016\/j.seizure.2020.01.002_bib0055","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.pediatrneurol.2013.09.006","article-title":"Levetiracetam-induced anaphylaxis in a neonate","volume":"50","author":"Koklu","year":"2014","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2020.01.002_bib0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4103\/0019-5154.177777","article-title":"Levetiracetam-induced drug reaction with eosinophilia and systemic symptom syndrome","volume":"61","author":"Dar","year":"2016","journal-title":"Indian J Dermatol"},{"issue":"2","key":"10.1016\/j.seizure.2020.01.002_bib0065","first-page":"1","article-title":"Drug reaction with eosinophilia and systemic symptoms syndrome in a patient taking Phenytoin and Levetiracetam: a Case Report","volume":"7","author":"Hall","year":"2013","journal-title":"J Med Case Rep"},{"issue":"2","key":"10.1016\/j.seizure.2020.01.002_bib0070","first-page":"89","article-title":"Spectrum of cutaneous adverse reactions to levetiracetam and human leukocyte antigen typing in North-Indian patients","volume":"6","author":"Bhargavi Ramanujam","year":"2016","journal-title":"J Epilepsy Res"},{"issue":"2","key":"10.1016\/j.seizure.2020.01.002_bib0075","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1665-2681(19)31663-1","article-title":"Severe acute hepatitis in DRESS syndrome: report of two cases","volume":"9","author":"Lens","year":"2010","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.seizure.2020.01.002_bib0080","series-title":"The oxford 2011 levels of evidence","author":"Howick","year":"2011"},{"issue":"2","key":"10.1016\/j.seizure.2020.01.002_bib0085","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","article-title":"Methodological quality and synthesis of case series and case reports","volume":"23","author":"Murad","year":"2018","journal-title":"Bmj Evid Med"},{"issue":"37","key":"10.1016\/j.seizure.2020.01.002_bib0090","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.seizure.2016.02.014","article-title":"Skin reaction following levetiracetam","volume":"2016","author":"Bhoi","year":"2016","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.seizure.2020.01.002_bib0095","first-page":"40","article-title":"Dose-related levetiracetam-induced reticulated drug eruption","volume":"9","author":"Beswick","year":"2010","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"10.1016\/j.seizure.2020.01.002_bib0100","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1592\/phco.31.4.440","article-title":"Levetiracetam-induced acute generalized exanthematous pustulosis","volume":"31","author":"Sultan","year":"2012","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.seizure.2020.01.002_bib0105","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4103\/0253-7613.201020","article-title":"Levetiracetam-induced leukocytoclastic vasculitis","volume":"49","author":"Gupta","year":"2017","journal-title":"Indian J Pharmacol"},{"issue":"7","key":"10.1016\/j.seizure.2020.01.002_bib0110","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ajem.2017.02.017","article-title":"Acute generalized exanthematous pustulosis secondary to levetiracetam and valproic acid use","volume":"35","author":"Levy","year":"2017","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.seizure.2020.01.002_bib0115","first-page":"1","article-title":"Toxic epidermal necrolysis with isolated neutropenia related to the use of levetiracetam","author":"Oh","year":"2016","journal-title":"J Dermatol"},{"key":"10.1016\/j.seizure.2020.01.002_bib0120","first-page":"1","article-title":"Drug reaction with eosinophilia and systemic symptoms syndrome induced by levetiracetam in a pediatric patient","author":"Bayram","year":"2015","journal-title":"J Emerg Med"},{"key":"10.1016\/j.seizure.2020.01.002_bib0125","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/jdv.12346","article-title":"Dress syndrome induced by Levetiracetam","volume":"29","author":"Eleni","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.seizure.2020.01.002_bib0130","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1345\/aph.1R084","article-title":"Levetiracetam induced drug reaction with eosinophilia and systemic symptoms syndrome","volume":"46","author":"Zorrilla","year":"2012","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.seizure.2020.01.002_bib0135","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2455-3972.196204","article-title":"Levetiracetam induced maculopapular rash: a rare side effect","volume":"2","author":"Unni","year":"2016","journal-title":"Indian J Drugs Dermatol."},{"key":"10.1016\/j.seizure.2020.01.002_bib0140","series-title":"Deeper than skin: a case of levetiracetam-induced drug reaction with eosinophilia and systemic symptoms in a patient with human immunodeficiency virus infection and toxoplasmosis presenting with altered mental status","author":"De Castro","year":"2019"},{"key":"10.1016\/j.seizure.2020.01.002_bib0145","first-page":"89","article-title":"Cross-sensitivity of Levetircetam and Carbamazepine induced skin rash","volume":"67","author":"Panda","year":"2019","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.seizure.2020.01.002_bib0150","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jsps.2015.02.010","article-title":"Levetiracetam induced psoriasiform drug eruption: a rare case report","volume":"23","author":"Gencler","year":"2015","journal-title":"Saudi Pharm J"},{"issue":"4","key":"10.1016\/j.seizure.2020.01.002_bib0155","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4103\/0019-5154.135546","article-title":"Levetiracetam induced urticarial vasculitis: a preliminary report","volume":"59","author":"Mangal","year":"2014","journal-title":"Indian J Dermatol"},{"issue":"2014","key":"10.1016\/j.seizure.2020.01.002_bib0160","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ebcr.2014.08.002","article-title":"A case of mycosis fungoides-like lesions developing after levetiracetam therapy","volume":"2","author":"Bora","year":"2014","journal-title":"Epilepsy Behav Case Rep"},{"issue":"2","key":"10.1016\/j.seizure.2020.01.002_bib0165","doi-asserted-by":"crossref","DOI":"10.5070\/D39346H1K6","article-title":"A case of erythema multiforme developing after levetiracetam therapy","volume":"19","author":"Yesilova","year":"2013","journal-title":"Dermatol Online J"},{"issue":"3","key":"10.1016\/j.seizure.2020.01.002_bib0170","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2147\/NDT.S2937","article-title":"Levetiracetam in the treatment of epilepsy","volume":"4","author":"Abou-Khalil","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"January 3","key":"10.1016\/j.seizure.2020.01.002_bib0175","article-title":"Drug reaction with eosinophilia and systemic symptoms syndrome in a patient taking phenytoin and levetiracetam: a case report","volume":"7","author":"Hall","year":"2013","journal-title":"J Med Case Rep"},{"issue":"3","key":"10.1016\/j.seizure.2020.01.002_bib0180","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.pharep.2014.11.009","article-title":"Anti-epileptic drugs and adverse skin reactions: an update","volume":"67","author":"Blaszuzyk","year":"2015","journal-title":"Pharmacol Rep"},{"issue":"June 1","key":"10.1016\/j.seizure.2020.01.002_bib0185","article-title":"Levetiracetam induced angioedema in a patient with previous anticonvulsant hypersensitivity reaction to phenytoin and lamotrigine","volume":"21","author":"Alkhotani","year":"2012","journal-title":"Seizure"},{"issue":"July 3","key":"10.1016\/j.seizure.2020.01.002_bib0190","article-title":"Risks and management of antiepileptic drug induced skin reactions in the adult out-patient setting","author":"Fowler","year":"2019","journal-title":"Seizure"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131119305758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131119305758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:54:17Z","timestamp":1761011657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131119305758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":38,"alternative-id":["S1059131119305758"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2020.01.002","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levetiracetam and cutaneous adverse reactions: A systematic review of descriptive studies","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2020.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}